GSK

NYSE: GSK · Real-Time Price · USD
39.16
0.36 (0.92%)
At close: Aug 15, 2025, 3:42 PM

GSK Income Statement

Financials in GBP. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
7.99B 7.52B 8.12B 8.01B 7.88B 7.36B 8.05B 8.15B 7.18B 6.95B 7.38B 7.83B 6.93B 9.78B 9.53B 9.08B 8.09B 7.42B
Cost of Revenue
2.17B 1.94B 2.56B 2.4B 2.08B 1.94B 2.34B 2.27B 1.93B 1.94B 2.24B 2.42B 2.18B 3.69B 3.68B 2.89B 2.55B 2.48B
Gross Profit
5.82B 5.58B 5.56B 5.62B 5.8B 5.43B 5.71B 5.88B 5.25B 5.01B 5.14B 5.41B 4.75B 6.09B 5.85B 6.19B 5.54B 4.94B
Operating Income
2.02B 2.22B 696M 189M 1.99B 1.98B 1.05B 1.95B 2.14B 2.08B 1.87B 1.19B 1.08B 2.8B 895M 1.94B 1.68B 1.69B
Interest Income
50M 54M -51M 32M 24M 32M 35.98M 24M 33M 29M 26M 22M 21M 7M 4M 4M 7M 10M
Pretax Income
1.89B 2.11B 563M 64M 1.5B 1.36B 380M 1.79B 1.99B 1.91B 1.63B 1.01B 896M 2.6B 706M 1.75B 1.47B 1.52B
Net Income
1.44B 1.62B 414M -58M 1.17B 1.05B 350M 1.46B 1.62B 1.49B 1.46B 779M 838M 1.8B 749M 1.37B 1.4B 1.07B
Selling & General & Admin
2.14B 2.07B 2.66B 3.8B 2.39B 2.07B 2.61B 2.3B 2.27B 2.14B 2.44B 2.06B 2.07B 2.84B 3.26B 2.65B 2.64B 2.43B
Research & Development
2.02B 1.46B 2.03B 1.46B 1.43B 1.37B 2.05B 1.57B 1.34B 1.26B 1.8B 1.35B 1.24B 1.17B 1.45B 1.49B 1.22B 1.12B
Other Expenses
-366M -169M 168M 167M n/a n/a n/a n/a n/a -477M -965M 813M 364M -722M -238M 114M -1M -300M
Operating Expenses
3.8B 3.36B 4.86B 5.43B 3.82B 3.44B 4.66B 3.93B 3.1B 2.93B 3.27B 4.21B 3.67B 3.29B 4.95B 4.25B 3.86B 3.25B
Interest Expense
184M 162M 144M 156M 174M 166M 275.41M 182M 185M 203M 270M 200M 204M 205M 191M 195M 192M 201M
Selling & Marketing Expenses
n/a n/a n/a n/a -75M -17M -65M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
5.96B 5.3B 7.42B 7.82B 5.9B 5.38B 7B 6.2B 5.04B 4.87B 5.51B 6.64B 5.85B 6.98B 8.63B 7.14B 6.42B 5.72B
Income Tax Expense
241M 336M 62M -1M 191M 274M -19M 257M 242M 276M 1M 233M 150M 431M -224M 380M -68M 258M
Shares Outstanding (Basic)
2.03B 2.04B 2.04B 2.04B 2.04B 2.03B 2.03B 2.03B 2.03B 2.02B 2.02B 2.02B 2.01B 2.01B 2B 2B 2B 2B
Shares Outstanding (Diluted)
2.06B 2.07B 2.07B 2.07B 2.06B 2.06B 2.06B 2.06B 2.05B 2.04B 2.05B 2.04B 2.03B 2.03B 2.04B 2.03B 2.02B 2.01B
EPS (Basic)
0.72 0.80 0.20 -0.03 0.58 0.52 0.17 0.72 0.80 0.74 0.74 0.38 0.42 0.90 0.38 0.58 0.70 0.54
EPS (Diluted)
0.70 0.78 0.20 -0.03 0.56 0.50 0.17 0.72 0.80 0.72 0.74 0.38 0.42 0.88 0.36 0.58 0.70 0.54
EBITDA
3.23B 3.09B 1.12B 1.17B 2.85B 2.8B 2.23B 2.55B 2.45B 2.56B 1.9B 3.5B 1.73B 3.52B 1.41B 2.93B 2.31B 1.52B
EBIT
2.07B 2.27B 707M 220M 1.67B 1.52B 602M 1.97B 2.17B 2.11B 1.84B 1.21B 1.1B 2.81B 899M 1.95B 1.65B 1.72B
Depreciation & Amortization
1.16B 823M 412M 951M 639M 549M 1.18B 579M 452M 640M 7M 956M 631M 704M 513M 986M 664M 361M